SCHEMBL6172633

SCHEMBL6172633

CCOC(=O)c1ccc([N+](=O)[O-])c(NC(=O)C(C)Cc2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
RAB9A P51151 3/20 0.49
CYP1A2 P05177 1/20 0.49
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
NPC1 O15118 2/20 0.46
PKM P14618 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
POLB P06746 2/20 0.45
KDM4E B2RXH2 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
ABCB1 P08183 3/20 0.44
PTGER4 P35408 1/20 0.44
ABCC1 P33527 1/20 0.43
GSTP1 P09211 1/20 0.41
GSTM2 P28161 1/20 0.41
MEN1 O00255 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6168965 0.89 RAB9A (0.48) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL6172436 0.86 KMT2A (0.50) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6170341 0.84 KMT2A (0.59) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6169030 0.83 KMT2A (0.52) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL6170000 0.82 KMT2A (0.57) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL6172642 0.81 RAB9A (0.56) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL6168964 0.80 RAB9A (0.48) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL8129523 0.79 ALDH1A1 (0.58) KMT2ARAB9AALDH1A1MAPTNPC1
SCHEMBL6170252 0.78 KMT2A (0.60) KMT2ARAB9ACYP1A2ALDH1A1MAPT
SCHEMBL6172669 0.78 KMT2A (0.52) KMT2ARAB9AALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed